Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma

Clinical trial NCT07174427 · RECRUITING

Trial details

NCT number: NCT07174427
Sponsor: Takara Bio Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Synovial Sarcomas

Start date: 2026-01-05
Primary completion: 2032-03-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.